UNLEASH IMMUNO ONCOLYTICS

unleash-immuno-oncolytics-logo

Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IOโ€™s leading product, UIO-512, is an oncolytic adenovirus that targets both malignant cells and tumor-associated stroma cells. UIO-512 is armed with GM-CSF, a potent immune-modulatory cytokine, triggering an immune response towards the tumor. UIO-512 lead indication is in ovarian cancer, follow on indications include other solid tumors such as glio... blastoma, melanoma and pancreatic cancer. Promising pre-clinical results in animal models and fresh human samples of ovarian cancers as well as in melanoma were published in top ranked peer-reviewed publications. Unleash IO is raising $3.5 M to conduct a phase I/II clinical trial in ovarian cancer with oncolytic immunotherapy UIO-512.

#SimilarOrganizations #People #Financial #Website #More

UNLEASH IMMUNO ONCOLYTICS

Social Links:

Industry:
Biotechnology Medical Device Therapeutics

Founded:
2015-01-01

Address:
Saint Louis, Missouri, United States

Country:
United States

Website Url:
http://www.unleash.bio

Total Employee:
1+

Status:
Active

Contact:
314-730-0050

Email Addresses:
[email protected]

Total Funding:
3 M USD

Technology used in webpage:
SPF Google Apps For Business Hostgator Mail A2 Hosting


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

nano-precision-medical-logo

Nano Precision Medical

Nano Precision Medical develops novel miniaturized subdermal implants

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

symphony-biosciences-logo

Symphony Biosciences

Symphony Biosciences empowers the immune system to fight cancer.

Current Employees Featured

ariel-muslera_image

Ariel Muslera
Ariel Muslera CFO @ Unleash Immuno Oncolytics
CFO

daniel-katzman_image

Daniel Katzman
Daniel Katzman CEO @ Unleash Immuno Oncolytics
CEO
2015-01-01

david-t-curiel_image

David T. Curiel
David T. Curiel CSO @ Unleash Immuno Oncolytics
CSO

Founder


david-t-curiel_image

David T. Curiel

Investors List

oncolys-biopharma-inc_image

Oncolys BioPharma

Oncolys BioPharma investment in Venture Round - Unleash Immuno Oncolytics

skandalaris-center-for-interdisciplinary-innovation-and-entrepreneurship_image

Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship

Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship investment in Grant - Unleash Immuno Oncolytics

Official Site Inspections

http://www.unleash.bio

  • Host name: 69.48.181.160.static.a2webhosting.com
  • IP address: 69.48.181.160
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Unleash Immuno Oncolytics"

UNLEASH - LinkedIn

UNLEASH | 45,183 followers on LinkedIn. A global innovation program for the United Nations Sustainable Development Goals! | UNLEASH enables young people to create solutions, become leaders, and ...See details»

UNLEASH - Dalberg

See details»

UNLEASH - PreventionWeb

UNLEASH is a non-profit organization with a mission to accelerate positive change toward the Sustainable Development Goals (SDGs) by mobilizing young talented people in community โ€ฆSee details»

WHO WE ARE - UNLEASH

Who we are UNLEASH is a non-profit organization with a mission to accelerate positive change toward the Sustainable Development Goals (SDGs) by mobilizing young talented people in community leadership, problem-solving, and โ€ฆSee details»

UNLEASH: a global innovation lab for the Sustainable

Mar 12, 2019 UNLEASH is a global initiative envisioning to build the worldโ€™s leading platform for novel and scalable solutions to reach the United Nations Sustainable Development Goals (SDGs). Each year, leading up to 2030, โ€ฆSee details»

WHAT WE DO - UNLEASH

What we do UNLEASH offers different programs for youth to co-create a sustainable future by addressing the Sustainable Development Goals (SDGs) in their community, region, or worldwide: UNLEASH Innovation Lab, global and โ€ฆSee details»

Our Impact - UNLEASH

Our Impact Our journey of impact started in 2017, with the very first Global Innovation Lab hosted in Denmark. Since then, weโ€™ve evolved from being an annual event-driven organization to leading different programs throughout the โ€ฆSee details»

COMMUNITY - UNLEASH

UNLEASH Community The UNLEASH Community unites and mobilizes changemakers from all over the world. From Innovation Lab participants to our partners, and from Ambassadors to UNLEASH Plus entrepreneurs โ€“ our โ€ฆSee details»

Unleash Immuno Oncolytics, Inc. - Drug pipelines, Patents, Clinical ...

Oct 6, 2024 Explore Unleash Immuno Oncolytics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 literature. Biomedical products. Data. Feature. Plans. Sign Up for Free. โ€ฆSee details»

PLUS FAQs - UNLEASH

UNLEASH Plus is a 6-month incubation program for early-stage social entrepreneurs who have a great idea and a phenomenal Team. The program supports Teams who are uniquely qualified โ€ฆSee details»

UNLEASH Rwanda - UNLEASH

UNLEASH Rwanda UNLEASH Rwanda is the very first Innovation Lab for the Sustainable Development Goals that UNLEASH has ever organized on the African continent. 1000 young โ€ฆSee details»

Unleash Immuno Oncolytics - Crunchbase Company Profile

Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IOโ€™s leading product, UIO โ€ฆSee details»

From the bottom up: Transforming Medidata with DevOps and โ€ฆ

Unleash reduces the risk of releasing new features, drives innovation by streamlining the software release process, and increases revenue by optimizing end-user experience. While we serve โ€ฆSee details»

Unleash | Enterprise AI Platform

Use Unleash enterprise AI platform to quickly and securely deploy AI experiences powered by your data, across every team in the organization. New case study - AU10TIX reduce their โ€ฆSee details»

Where the HR world meets | 20-22 October 25 - UNLEASH World

UNLEASH has championed HR excellence and disruption since 2011 and has become the global destination on the new ways of working and the industry standard that drives progress in โ€ฆSee details»

BIO Announces Dedicated Focus on Human Health and โ€ฆ

Washington, DC, May 28, 2025 โ€“ The Biotechnology Innovation Organization (BIO) today announced plans to dedicate its focus entirely to human health and to transition the work of its โ€ฆSee details»

Unleashed | Strengths-Based Coaching & Consulting for โ€ฆ

Consultant Bio. Alesha Arscott is the Founder and Chief Executive Officer for Unleashed, a coaching and consulting firm dedicated to implementing strengths-based practices with โ€ฆSee details»

Unleash & Engage help you help your people help each other

At Unleash & Engage, we can improve all aspects of your business. We do this by helping you help your people help each other. When people in any organisation communicate and โ€ฆSee details»

Unleash Immuno Oncolytics - teaserclub.com

Unleash Immuno Oncolytics Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IOโ€™s โ€ฆSee details»

Unleash Immuno Oncolytics - insights.citeline.com

Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

linkstock.net © 2022. All rights reserved